VistaPharm, Inc. recalls NYSTATIN Oral Suspension, USP 500,000 Units/5mL, unit dose 5ml cups, packaged in a) 50 unit dose cups (10x5ml unit dose…
- Recall date
- November 30, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0348-2019
- FDA classification
- Class III
- Brand / firm
- VistaPharm, Inc.
- Sold / distributed
- Nationwide in the USA and Puerto Rico
Why it was recalled
Failed Impurities/Degradation Specifications:Out of specification for impurities.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
NYSTATIN Oral Suspension, USP 500,000 Units/5mL, unit dose 5ml cups, packaged in a) 50 unit dose cups (10x5ml unit dose cups per tray, 5 trays per case) NDC 66689-037-50; b) 100 unit dose cups (10x5ml unit dose cups per tray, 10 trays per case) NDC 66689-037-99. Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771
Get recall alerts
Free email alert whenever VistaPharm, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: VistaPharm, Inc.